Updated May 2016
Submissions to HPP are accepted through our
online submission system. To streamline the process, the online submission
system is designed to perform a series of automatic controls, promptly informing
the user of any technical insufficiencies, and directing to the relevant
To start submission, please create an account and log in. The submitting
author will take responsibility on behalf of all co-authors as the corresponding
author of the submission, and is required to enter full details including a
working e-mail address, phone number and address, in their online profile. All
correspondence, including, but not limited to, the results of initial
evaluation, Editor’s decision, and request for revisions or proofreading will be
sent to the e-mail address of the corresponding author, which will be published
with the article.
The submission or any subsequent revision is evaluated at the editorial
office, and if corrections are necessary, it may be temporarily unsubmitted and
returned to the authors, who are responsible for formatting their submission and
providing the required information. Please see our editorial workflow for more
information. For further help regarding submission, you may contact the
We use iThenticate software in the processing of the submissions.
1. The conditions of submission
Open access license, copyright, and charges
Upon submission, the authors are required to sign an exclusive license form
for open access publication of their work in the journal under the Creative
Commons license 4.0 (CC-BY). The authors retain the copyright to their work.
Please see our open access and copyright policy and license agreement for more
Currently, there are no submission or publication charges applicable to the
articles submitted to or published in HPP, the open
access publication of which is supported by Tabriz University of Medical
Sciences Department of Vice Chancellor for Research. Please see our open access
and copyright policy for more information.
A cover letter is required for every submission. The authors will need to
confirm the following conditions in the submission cover letter:
- That the submission is original, submitted solely to this journal, and not
currently under consideration for publication or already published elsewhere,
unless explained in the submission cover letter. See our editorial
policies on duplicate publication.
- That no any sentence is copied from other sources. See our editorial
policies on plagiarism and text
- That the submitting author takes responsibility for the submission on behalf
of all authors as the corresponding author.
- That all authors have reviewed, approved, and consented to the submission,
and they are accountable for all aspects of its accuracy and integrity in
accordance with ICMJE criteria.
The submission cover letter should also include the following information, as
well as any additional information requested in the instructions for the
specific article type that the authors are submitting:
- An explanation of why the submitted work should be published in the journal
(the novelty of the work).
- An explanation of any issues relating to journal policies.
- A declaration of any potential competing interests.
- The name of particular special issue that the submission should be published
The authors may also suggest potential peer reviewers for their submission by
providing name, institutional email addresses, and an ORCID or Scopus ID. Please
see our editorial
policies for more information on suggesting peer reviewers. Please also see
policies regarding the use of unique identifiers.
The authors may also provide the details of anyone who they would prefer not
to review their work.
Intentionally providing falsifying information, such as false names or email
addresses, will result in rejection of the submission and may lead to further
investigation in line with our misconduct
Title page should include the manuscript title, authors' full names and affiliations, corresponding author's name and affiliation.
2. Preparing the submission
Preparing the manuscript
For general instructions, please see preparing
the manuscript. HPP publishes these article
- Research article: Original work resulting from
research, constituting complete studies that contain all relevant information.
Including systematic review and meta-analysis. Prepare the manuscript as
follows: A Title, a Structured Abstract, Key words, Introduction, Methods,
Results, Discussion, Conclusion, References, Tables, Legend for figures, List of
- Short communication: Original work, but less
substantial than the regular research article, presenting preliminary results,
or results of immediate relevance. Prepare the manuscript as follows: A Title, a
Structured Abstract, Key words, Introduction, Methods, Results, Discussion,
Conclusion, References, Tables, Legend for figures, List of additional files.
- Review: Narrative reviews on clinically
relevant topics. Prepare the manuscript as follows: A Title, an Unstructured
Abstract, Key words, Introduction, Subheadings in the manuscript as necessary,
Discussion, Conclusion, References, Tables, Legend for figures, List of
- Case report: Systematic reports of interesting
or rare cases of importance for the practice of professionals. Prepare the
manuscript as follows: A Title, an Unstructured Abstract, Key words,
Introduction, Case Report, Discussion, Conclusion, References, Tables, Legend
for figures, List of additional files.
- Letter: Comments or concerns on specific
subjects; overall or pertaining to items published in the journal. Also, new or
additional findings of original nature. Prepare the letter as follows: A Title,
- Editorial: The Journal’s editors write the
A concise descriptive title should be chosen for the submission. Do not
capitalize all words; only the first word and proper nouns should be
capitalized. Include the type of the study (meta-analysis, systematic review,
cohort, case report, etc.) in the title with a colon (:).
The structured abstract (maximum 250 words) is to contain the following major
subheadings: Background, Methods, Results, and Conclusion. The Background
subheading reflects the background as well as the purpose of the study, that is,
the hypothesis being tested. The Methods should include the setting for the
study, the subjects (number and type), the treatment or intervention, and the
type of statistical analysis. The Results include the outcome of the study and
statistical significance if appropriate. The Conclusion states the significance
of the results. Clinical trials should include the trial registration number on
the last line of the abstract.
The unstructured abstract (maximum 150 words) does not contain subheadings.
Three to 10 key words for each submission should be selected from the list of
MESH words. List key words in alphabetic order, all lower case, except where
The introduction contains a concise review of the subject area and the
rationale for the study. More detailed comparisons to previous work and
conclusions of the study appear in the Discussion section.
The methods section should describe in adequate detail the experimental
subjects, their important characteristics, and the methods, apparatus, and
procedures used so that other researchers can reproduce the experiment.
When reporting experiments on human subjects, authors should indicate whether
the procedures followed were in accordance with the ethical standards of the
responsible committee on human experimentation (institutional and national) and
with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists
whether the research was conducted in accordance with the Helsinki Declaration,
the authors must explain the rationale for their approach and demonstrate that
the institutional review body explicitly approved the doubtful aspects of the
study. When reporting experiments on animals, authors should indicate whether
the institutional and national guide for the care and use of laboratory animals
The methods section must indicate that the protocol was reviewed by the
appropriate institutional review body and that each subject in the project
signed a detailed informed consent form.
Results should be presented in a logical sequence with reference to tables,
figures, and illustrations as appropriate.
New and possible findings of the study should be emphasized, as well as any
conclusions that can be drawn. The discussion should compare the present data to
previous findings. Limitations of the experimental methods should be indicated,
as should implications for future research. New hypotheses and clinical
recommendations are appropriate and should be clearly identified.
Recommendations, particularly clinical ones, may be included when
Preparing references, equations, tables, figures, and additional
To correctly prepare the references, equations, tables, figures, or
additional files for a submission, please follow these guidelines:
- For instructions on formatting the citations of the submission, please see
references. Additionally The EndNote style for references, can be downloaded here.
- For correct formatting of formulas, please see preparing
formulas or equations.
- Smaller tables that are considered integral to the manuscript can be pasted
at the end of the manuscript file in A4 portrait or landscape format. Tables may
also be uploaded separately. Please see preparing
tables for more instructions.
- Figures must be submitted separately in a proper format (and also embedded
in the manuscript to expedite the review process). Please see preparing
figures for more instructions.
- Datasets, large tables, videos, or other information must be submitted
separately as additional files, which will be published along with the article.
Please see preparing
additional files for more instructions.
3. Providing the required information
The authors should have the required information below ready upon submission.
The manuscript should not include this information to ensure a blind
peer-review. Please see our editorial
policies for more information regarding peer review policy. The supporting
information will be reviewed by the editor.
Author information and acknowledgments
Full names and email addresses of all authors, as well as their affiliations
and institutional addresses are requested during submission. Providing the
unique identifier (ORCID or Scopus ID) of each co-author is optional, but
preferred. Please see our editorial
policies on authorship and unique
identifiers for more information. If a collaboration group should be listed
as an author, please list the group name as an author.
In an “Authors’ contribution” section, the authors are required to explain
the contribution of each co-author in the conception or design of the work; the
acquisition, analysis, or interpretation of data for the work; and drafting the
work or revising it critically for important intellectual content.
In an “Acknowledgments” section, the authors are required to acknowledge
anyone who contributed to the submitted work who does not meet the criteria for
authorship. It is obligatory to state any support with translating or editing by
third parties such as professional commercial writing/editing services. The
authors should obtain permission to acknowledge from all those mentioned in the
Please see our editorial
policies for further explanation of authorship criteria and acknowledgments.
The authors are required to declare all sources of funding for the research
reported. The role of the funding body in the design of the study and
collection, analysis, and interpretation of data and in writing the manuscript
should be declared.
The authors are required to declare all financial and non-financial competing
interests with regards to the publication of their work during submission.
Please see our editorial
policies for more information on competing interests. If any of the authors
are unsure whether they have a competing interest, they should contact the
Ethics approval and consent to participate
Authors of submissions reporting studies involving human participants, human
data, or human tissues are required to provide the following information:
- A statement on ethics approval and consent (even where the need for approval
- The name of the ethics committee that approved the study and the committee’s
reference number if appropriate.
Submissions reporting studies involving animals must include a statement on
Please see our editorial
policies for more information.
If the submission does not report on or involve the use of any animals or
human data or tissues, please state “Not applicable” in this section.
Consent to publish
If the submission contains any individual person’s data in any form, consent
to publish must be obtained from that person, or in the case of children, their
parent or legal guardian. All presentations of case reports must have consent to
publish. The authors may use their institutional consent form. The form is not
to be sent on submission, but we may request to see a copy at any stage
(including after publication).
Please see our editorial
policies for more information.
If the submission does not contain any individual person’s data, please state
“Not applicable” in this section.
4. Finalizing submission
Before completing the process, the submitting author is required to review
the submission proof (PDF) which will be automatically generated. The submission
proof may be shared with co-authors for a final check and approval. The
submitting author may go back and correct any parts as necessary, review the
submission proof again, and then submit the work using the “Submit” button.
5. Revising the submission
Any subsequent revisions to the submission upon request from the editor will
have to follow the same guidelines presented here.
Upon submitting a revised submission, the authors will be guided to provide a
re-submission letter, attaching the revision details, based on the comments
provided by the editor. The attached revision details should not include author
information to ensure blind peer review.
6. Author Contributions
According to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals”, those individuals claiming authorship should meet all 4 of the following conditions:
1. Contributed substantially to the conception and design of the study, the acquisition of data, or the analysis and interpretation
2. Drafted or provided critical revision of the article
3. Provided final approval of the version to publish
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Ghost-writing is NOT acceptable. Contributors who do not meet the abovementioned criteria for authorship should be listed in the acknowledgment.
Groups of persons who have contributed materially to the paper, but whose contributions do not justify authorship may be listed under a heading such as “clinical investigators” or “participating investigators,” and their function or contribution should be described; for example, “served as scientific advisors,” “critically reviewed the study proposal.”]
If you have any question about this, contact that editorial office before submitting your manuscript at firstname.lastname@example.org or +98413-337-41-90.
Author Contribution Details
Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed along with the article.
HA involved in the conception and designing the study. MAJ performed the data analysis and interpretation. HN wrote the manuscript and acted as corresponding author. HA and ID supervised the development of work, helped in data interpretation and manuscript evaluation. HN helped to evaluate and edit the manuscript.